AMT-080

DB17846ExperimentalGene Therapies

AMT-080 is an investigational gene therapy being investigated for the treatment of Duchenne muscular dystrophy.

Code names
AMT-080

Which companies are running trials of AMT-080, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In